@karli.sine's peptide claims need a reality check

What does this video actually claim?

Karli Sine promotes multiple peptides as "game-changers" for fat loss, muscle recovery, and endurance. Her Instagram post lists sermorelin, BPC-157, TB-500, GLP-1 peptides, NAD, and GHK-Cu as having specific benefits for burning fat, building strength, recovery, and boosting energy.

She offers to send followers links for "a full breakdown of each one and how they work" if they comment "BOOST." The post targets people "serious about fat loss" and positions these peptides as performance enhancers for various fitness goals.

What does the science actually show?

The evidence varies wildly depending on which peptide we're talking about. GLP-1 agonists like semaglutide have solid clinical data, with the STEP 1 trial (Wilding et al., NEJM, 2021) showing 14.9% weight loss at 68 weeks.

But most of the other peptides she mentions? The human evidence is thin to nonexistent. BPC-157 has shown promise in animal studies for tissue repair, but there's no published human clinical trial data proving it works for muscle recovery. TB-500 is even murkier, with most research happening in horses and rats.

Sermorelin can increase growth hormone levels, but the 2006 study by Khorram et al. in older adults showed modest effects that don't justify calling it a "game-changer." GHK-Cu has some interesting wound healing properties in small studies, but calling it a performance booster oversells the evidence.

What's the regulatory reality here?

Here's where things get messy. Most peptides Sine promotes exist in a regulatory gray zone. The FDA hasn't approved BPC-157, TB-500, or many other "research peptides" for human therapeutic use.

Compounding pharmacies can legally make some peptides like sermorelin with a prescription, but quality control varies significantly. The peptide market is flooded with products of questionable purity and potency from online vendors.

GLP-1 medications are the exception. They're FDA-approved prescription drugs with established safety profiles and proper manufacturing oversight.

What are the real risks?

Sine's post doesn't mention side effects or risks, which is a red flag. Even well-studied peptides can cause problems.

Sermorelin can cause injection site reactions, headaches, and flushing. GLP-1 agonists commonly cause nausea, vomiting, and diarrhea. More seriously, they carry risks of pancreatitis and gallbladder problems.

The unregulated peptides are bigger wildcards. You're essentially experimenting with compounds that lack human safety data. Contamination, incorrect dosing, and unknown long-term effects are all real concerns when sourcing peptides from sketchy suppliers.

What should you actually know?

If you're interested in peptides, stick to the ones with actual human evidence and proper medical oversight. GLP-1 agonists work for weight loss but require careful medical supervision.

For everything else, manage your expectations. The peptide industry thrives on selling hope based on preliminary research that often doesn't translate to humans. Most of the dramatic before-and-after stories you see aren't from peptides alone.

Work with a qualified healthcare provider who can help you separate marketing hype from medical reality. They can guide you toward evidence-based options that actually match your goals without unnecessary risks.